Concepedia

Publication | Open Access

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

DOIFull Paper Access

41

Citations

27

References

2016

Year

Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella, Federico Monaco, Debora Degl’Innocenti, Flavia Salvi, Umberto Vitolo, Lisa Argnani, Paolo Corradini, Pier Luigi Zinzani
Journal of Hematology & Oncology

Abstract

The trial was registered under EudraCT 2012-001404-38; ClinicalTrials.gov number, NCT01822886 .

References

YearCitations

Page 1